In a report released yesterday, Gregory Lewis from BTIG maintained a Hold rating on Genco Shipping (GNK – Research Report). The company’s ...

BTIG analyst Ryan Zimmerman upgraded Treace Medical (TMCI) to Buy from Neutral with a $16 price target The company has pivoted away from ...

HOPE Therapeutics™, Inc. ("HOPE"), a medical and technology driven company, and a wholly-owned subsidiary of NRx ...

InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that Yair Malca, Chief Financial Officer will host investor meetings at the BTIG MedTech, ...

Research analysts at BTIG Research reduced their Q4 2025 earnings estimates for shares of D.R. Horton in a research note ...

BTIG analyst Lance Jessurun reaffirmed a Neutral rating on PayPal (NASDAQ:PYPL) stock, expressing caution ahead of the ...

Robeco Institutional Asset Management B.V. lowered its stake in shares of MGM Resorts International (NYSE:MGM – Free Report) ...

The Company has recently announced execution of an agreement for $27 million in funding for HOPE <a target=_blank href= ...

Market technician Jonathan Krinsky analyzes the shift in market leadership from technology to healthcare amid recent ...

BTIG analyst Mark Massaro announced an increased price target for IDEXX Laboratories (NASDAQ:IDXX), raising it from $500 to $530, while maintaining a Buy rating on the stock. The revision follows ...

Blank check company Rithm Acquisition, which is affiliated with Rithm Capital, filed for a $200 million initial public offering on Monday. The company said Michael Nierenberg, its chairman and chief ...

Physicians also expect greater use of Johnson & Johnson’s Varipulse system over the next two years despite the company’s ...